UNIVERSITY OF NEBRASKA MEDICAL CENTER
Imaging Biomarker for Determining Antiretroviral-induced Neurodevelopmental Impairments
Imaging Biomarker for Determining Antiretroviral-induced Neurodevelopmental Impairments is a funding opportunity from UNIVERSITY OF NEBRASKA MEDICAL CENTER, up to 422125, closing June 30, 2027.
Jun 30, 2027
(334d left)Overview
Project Summary Background: Children born to mothers with human immunodeficiency virus type-1 (HIV-1) infection are on the rise. With an increased coverage of antiretrovirals (ARVs) for pregnant women, especially in in resource-limited countries (RLCs), over one million ARV-exposed-HIV-1-uninfected (HEU) children are…